LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Myocardial ischaemia and valve insufficiency caused by a dysplastic aortic valve cusp: a previously unreported unique morphologic anomaly - CORRIGENDUM.

    Samuel, Sharmeen / Dhanantwari, Preeta / Misra, Nilanjana / Meyer, David B

    Cardiology in the young

    2020  Volume 30, Issue 9, Page(s) 1380

    Language English
    Publishing date 2020-07-30
    Publishing country England
    Document type Journal Article ; Published Erratum
    ZDB-ID 1078466-4
    ISSN 1467-1107 ; 1047-9511
    ISSN (online) 1467-1107
    ISSN 1047-9511
    DOI 10.1017/S1047951120002218
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Myocardial ischaemia and valve insufficiency caused by a dysplastic aortic valve cusp: a previously unreported unique morphologic anomaly.

    Samuel, Sharmeen / Dhanantwari, Preeta / Meyer, David B

    Cardiology in the young

    2020  Volume 30, Issue 7, Page(s) 1046–1049

    Abstract: Isolated aortic regurgitation and myocardial infarction are a rare congenital defect among neonatal patients. We present a case of a neonate with an unusual aortic valve morphology causing both regurgitation and obstruction of the left coronary artery ... ...

    Abstract Isolated aortic regurgitation and myocardial infarction are a rare congenital defect among neonatal patients. We present a case of a neonate with an unusual aortic valve morphology causing both regurgitation and obstruction of the left coronary artery ostium. Despite both non-invasive and invasive imaging modalities, accurate diagnosis of the valve morphology was only determined by direct visualisation at the time of surgical repair. To the knowledge of authors, this particular aortic valve morphology in neonatal population has not been previously reported in the literature.
    MeSH term(s) Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Insufficiency/diagnosis ; Aortic Valve Insufficiency/etiology ; Aortic Valve Insufficiency/surgery ; Coronary Artery Disease ; Humans ; Infant, Newborn ; Myocardial Ischemia ; Sinus of Valsalva
    Language English
    Publishing date 2020-06-11
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1078466-4
    ISSN 1467-1107 ; 1047-9511
    ISSN (online) 1467-1107
    ISSN 1047-9511
    DOI 10.1017/S1047951120001377
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comparison of C-Reactive Protein and White Blood Cell Count as Predictors of Infectious Complications after Colorectal Surgery: A Single-Center Experience.

    Kim, Samuel / Husain, Sharmeen / Boustany, Marc

    The American surgeon

    2018  Volume 84, Issue 8, Page(s) e337–e339

    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; Colectomy/adverse effects ; Colorectal Neoplasms/surgery ; Female ; Humans ; Laparoscopy/adverse effects ; Laparotomy/adverse effects ; Length of Stay/statistics & numerical data ; Leukocyte Count/methods ; Male ; Middle Aged ; ROC Curve ; Retrospective Studies ; Surgical Wound Infection/diagnosis ; Surgical Wound Infection/epidemiology
    Chemical Substances C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2018-11-19
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 202465-2
    ISSN 1555-9823 ; 0003-1348
    ISSN (online) 1555-9823
    ISSN 0003-1348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.

    Brown, Kelly A / Samuel, Sharmeen / Patel, Dilip R

    Translational pediatrics

    2018  Volume 7, Issue 1, Page(s) 36–47

    Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD ... ...

    Abstract Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
    Language English
    Publishing date 2018-01-26
    Publishing country China
    Document type Journal Article ; Review
    ZDB-ID 2901309-4
    ISSN 2224-4344 ; 2224-4344 ; 2224-4336
    ISSN (online) 2224-4344
    ISSN 2224-4344 ; 2224-4336
    DOI 10.21037/tp.2017.08.02
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A Unique Case of Sudden Cardiac Death in an Infant.

    Samuel, Sharmeen / Fountain, Robin / Start, David / Karpawich, Peter P

    Clinical pediatrics

    2018  Volume 58, Issue 2, Page(s) 253–256

    MeSH term(s) Cardiomyopathies/complications ; Cardiomyopathies/congenital ; Cardiomyopathies/diagnosis ; Death, Sudden, Cardiac/etiology ; Diagnosis, Differential ; Electrocardiography/methods ; Electrocardiography, Ambulatory ; Electron Transport Complex III/deficiency ; Fatal Outcome ; Female ; Humans ; Infant ; Wolff-Parkinson-White Syndrome/complications ; Wolff-Parkinson-White Syndrome/diagnosis
    Chemical Substances Electron Transport Complex III (EC 1.10.2.2)
    Language English
    Publishing date 2018-11-17
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 207678-0
    ISSN 1938-2707 ; 0009-9228
    ISSN (online) 1938-2707
    ISSN 0009-9228
    DOI 10.1177/0009922818812477
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Determinants of hypertension among adults in Bangladesh as per the Joint National Committee 7 and 2017 American College of Cardiology/American Hypertension Association hypertension guidelines.

    Kibria, Gulam Muhammed Al / Swasey, Krystal / Hasan, Md Zabir / Choudhury, Allysha / Gupta, Rajat Das / Abariga, Samuel A / Sharmeen, Atia / Burrowes, Vanessa

    Journal of the American Society of Hypertension : JASH

    2018  Volume 12, Issue 11, Page(s) e45–e55

    Abstract: We investigated determinants of hypertension in Bangladesh using both Joint National Committee 7 (JNC7) and 2017 American College of Cardiology/American Hypertension Association (2017 ACC/AHA) guidelines. After reporting background characteristics, odds ... ...

    Abstract We investigated determinants of hypertension in Bangladesh using both Joint National Committee 7 (JNC7) and 2017 American College of Cardiology/American Hypertension Association (2017 ACC/AHA) guidelines. After reporting background characteristics, odds ratios (ORs) were obtained by multilevel logistic regression. Among 7839 respondents aged ≥35 years, 25.7% (n = 2016) and 48.0% (n = 3767) respondents had hypertension as per the JNC7 and 2017 ACC/AHA guidelines, respectively. The following factors were significant according to the 2017 ACC/AHA guideline: ≥65 years (adjusted OR [AOR]: 2.4, 95% confidence interval [CI]: 2.2-3.0), 55-64 years (AOR: 1.6, 95% CI: 1.4-1.9), and 45-54 years (AOR: 1.4, 95% CI: 1.3-1.6) age groups, females (AOR: 2.0, 95% CI: 1.7-2.2), overweight/obesity (AOR: 2.4, 95% CI: 2.0-2.8), diabetes (AOR: 1.4, 95% CI: 1.2-1.6), secondary (AOR: 1.2, 95% CI: 1.1-1.4), or college education level (AOR: 1.8, 95% CI: 1.4-2.3), middle (AOR: 1.3, 95% CI: 1.1-1.6), richer (AOR: 1.5, 95% CI: 1.2-1.8) or richest (AOR: 2.0, 95% CI: 1.6-2.4) wealth quintiles, residence in Khulna (AOR: 1.5, 95% CI: 1.2-1.9), and Rangpur (AOR: 1.7, 95% CI: 1.3-2.2) divisions. All factors were significant as per the JNC7 guideline too. Both guidelines found similar determinants. Prevention and control programs should prioritize increasing awareness among people with higher likelihood of hypertension.
    Language English
    Publishing date 2018-10-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2276144-5
    ISSN 1878-7436 ; 1933-1711
    ISSN (online) 1878-7436
    ISSN 1933-1711
    DOI 10.1016/j.jash.2018.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Ten-Year Clinical Experience with the Lumenless, Catheter-Delivered, 4.1-Fr Diameter Pacing Lead in Patients with and without Congenital Heart.

    Bansal, Neha / Samuel, Sharmeen / Zelin, Kathleen / Karpawich, Peter P

    Pacing and clinical electrophysiology : PACE

    2017  Volume 40, Issue 1, Page(s) 17–25

    Abstract: Background: Patients with congenital heart defects (CHD) often present more challenges to pacing therapy due to anatomy than those without CHD. The lumenless, 4.1Fr diameter M3830 pacing lead (Medtronic, Inc., Minneapolis, MN, USA), approved for use in ... ...

    Abstract Background: Patients with congenital heart defects (CHD) often present more challenges to pacing therapy due to anatomy than those without CHD. The lumenless, 4.1Fr diameter M3830 pacing lead (Medtronic, Inc., Minneapolis, MN, USA), approved for use in 2005, has, to date, reported to have excellent short-term (<6 years) lead performance. Unfortunately, very long-term performance is unknown, especially among CHD patients and with implants at alternate pacing (AP) sites. This study reports a 10-year clinical experience with the M3830 lead.
    Methods: Records of patients who received the M3830 lead were reviewed: patient demographics, implant techniques and locations, sensing and pacing characteristics, impedances (Imp), and any complications at implant and follow-up.
    Results: From 2005 to 2015, 141 patients (ages 2-50, mean 20.1 years, 57% males) received 212 leads: atrial 115; ventricle 97. CHD was present in 62% of patients. Leads were inserted at AP sites in 96% of patients. Postimplant follow-up was from 3 months to 10 years (mean 56.3 months). Comparative implant versus follow-up values (mean ± standard deviation) were available on 196 leads (92.5%), showing persistently low (<1 v @ 0.4-0.5 ms) pacing thresholds (P = 0.57). Sensing was also comparable (atrial leads, P = 0.41; ventricular leads, P = 0.9). Impedances differed (P < 0.05) but remained within the normal range. Two A leads became dislodged and one was repositioned while two other leads (1 A, 1 V) were extracted. There are no differences observed in the pacing characteristics between the CHD and non-CHD groups on follow-up.
    Conclusions: The 4.1Fr lumenless pacing lead shows ease of implant regardless of CHD or AP site, excellent very long-term (10 years) stability, and performance indices with a very low rate of complications.
    MeSH term(s) Adolescent ; Adult ; Arrhythmias, Cardiac/epidemiology ; Arrhythmias, Cardiac/prevention & control ; Cardiac Catheterization/statistics & numerical data ; Cardiac Pacing, Artificial/statistics & numerical data ; Child ; Child, Preschool ; Equipment Design ; Equipment Failure/statistics & numerical data ; Equipment Failure Analysis ; Female ; Heart Defects, Congenital/epidemiology ; Heart Defects, Congenital/therapy ; Humans ; Longitudinal Studies ; Male ; Michigan/epidemiology ; Pacemaker, Artificial/statistics & numerical data ; Prevalence ; Prosthesis Implantation/methods ; Prosthesis Implantation/statistics & numerical data ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Young Adult
    Language English
    Publishing date 2017-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 424437-0
    ISSN 1540-8159 ; 0147-8389
    ISSN (online) 1540-8159
    ISSN 0147-8389
    DOI 10.1111/pace.12995
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.

    Samuel, Sharmeen / Friedman, Richard A / Sharma, Chetan / Ganigara, Madhusudan / Mitchell, Elizabeth / Schleien, Charles / Blaufox, Andrew D

    Heart rhythm

    2020  Volume 17, Issue 11, Page(s) 1960–1966

    Abstract: Background: There is limited data regarding the electrophysiological abnormalities and arrhythmias in children with COVID-19, including those associated with treatment using potentially proarrhythmic hydroxychloroquine (HCQ) and azithromycin (AZN).: ... ...

    Abstract Background: There is limited data regarding the electrophysiological abnormalities and arrhythmias in children with COVID-19, including those associated with treatment using potentially proarrhythmic hydroxychloroquine (HCQ) and azithromycin (AZN).
    Objectives: To describe the electrophysiologic findings and arrhythmias associated with pediatric COVID-19 and its treatment.
    Methods: A single-center retrospective chart review was undertaken and included all patients with (1) symptoms of COVID-19 and (2) PCR-positive nasopharyngeal swabs for SARS-CoV-2 who were placed on continuous telemetry for the duration of their hospitalization during March through May, 2020.
    Results: Thirty-six patients were included in the study. Significant arrhythmias were found in 6 (nonsustained ventricular tachycardia in 5 and sustained atrial tachycardia in 1). All were self-resolving and half prompted prophylactic antiarrhythmic therapy. Patients with significant arrhythmias were likely to have noncardiac comorbidities (4/6), but these were not more common than in patients without arrhythmias (20/30, P = 1). The use of HCQ was associated with statistically significant QTc prolongation (413 ± 19 ms vs 425 ± 16 ms, P =.005). QTc was not statistically different in patients with and without arrhythmias (425 ± 15 ms vs 425 ± 15 ms, P = 1).
    Conclusions: In pediatric patients with PCR-positive active COVID-19 infection, significant arrhythmias are infrequent, but are more common than expected in a general pediatric population. Comorbidities are not more common in patients with arrhythmias than in patients without arrhythmias. COVID-19 treatment using HCQ is associated with QTc prolongation but was not associated with arrhythmias in pediatric patients.
    MeSH term(s) Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/adverse effects ; Arrhythmias, Cardiac/diagnosis ; Arrhythmias, Cardiac/epidemiology ; Azithromycin/administration & dosage ; Azithromycin/adverse effects ; Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; Child ; Clinical Laboratory Techniques/methods ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/physiopathology ; Electrocardiography/methods ; Electrocardiography/statistics & numerical data ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Hydroxychloroquine/adverse effects ; Incidence ; Long QT Syndrome/chemically induced ; Long QT Syndrome/diagnosis ; Male ; New York City/epidemiology ; Outcome and Process Assessment, Health Care ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/physiopathology ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
    Chemical Substances Anti-Infective Agents ; Hydroxychloroquine (4QWG6N8QKH) ; Azithromycin (83905-01-5)
    Keywords covid19
    Language English
    Publishing date 2020-07-01
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 2229357-7
    ISSN 1556-3871 ; 1547-5271
    ISSN (online) 1556-3871
    ISSN 1547-5271
    DOI 10.1016/j.hrthm.2020.06.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Human Metapneumovirus Infection in Immunocompromised Patients.

    Samuel, Sharmeen / Nanjappa, Sowmya / Cooper, Christopher D / Greene, John N

    Cancer control : journal of the Moffitt Cancer Center

    2016  Volume 23, Issue 4, Page(s) 442–445

    Abstract: Human metapneumovirus (HMPV) is a pathogen associated with respiratory tract infection and is related to avian pneumovirus. Typically, children, the elderly, and those who are immunocompromised are the most susceptible to HMPV infection; however, the ... ...

    Abstract Human metapneumovirus (HMPV) is a pathogen associated with respiratory tract infection and is related to avian pneumovirus. Typically, children, the elderly, and those who are immunocompromised are the most susceptible to HMPV infection; however, the virus can infect persons of all ages. In otherwise healthy individuals, HMPV infection is generally self-limiting, but immunocompromised individuals can develop fatal complications. We present a case series of 3 severely immunocompromised patients who were infected with HMPV and describe their clinical course. All 3 patients had acute myeloid leukemia, histories of neutropenic fever, and prolonged hospitalization stays. This case series highlights the severe sequelae observed in individuals infected with HMPV, particularly among those who are immunocompromised.
    MeSH term(s) Female ; Humans ; Immunocompromised Host ; Male ; Metapneumovirus/pathogenicity ; Middle Aged ; Respiratory Tract Infections/complications
    Language English
    Publishing date 2016-10
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1328503-8
    ISSN 1526-2359 ; 1073-2748
    ISSN (online) 1526-2359
    ISSN 1073-2748
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval

    Samuel, Sharmeen / Friedman, Richard A. / Sharma, Chetan / Ganigara, Madhusudan / Mitchell, Elizabeth / Schleien, Charles / Blaufox, Andrew D.

    Heart Rhythm

    2020  Volume 17, Issue 11, Page(s) 1960–1966

    Keywords Physiology (medical) ; Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2229357-7
    ISSN 1556-3871 ; 1547-5271
    ISSN (online) 1556-3871
    ISSN 1547-5271
    DOI 10.1016/j.hrthm.2020.06.033
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top